Search

everythinglearnresearchcommunity

for

Search:↓

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

The article concludes that cranial reconstruction should aim for the best aesthetic result, using various techniques tailored to individual needs and conditions.

The book has valuable information but is hard to read due to poor writing.

The document concludes that some dermatology books are useful for their photos or specific topics, while others have limitations like poor quality images or content.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

The position of the parietal whorl can predict safe donor areas for hair transplants in Korean men with male pattern baldness.

Different areas of the scalp have varying hair thickness, useful for different types of hair transplant needs.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Current treatments for alopecia show no significant long-term benefits.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Non-immune factors play a significant role in alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.